Venlafaxine Hydrochloride
Product Images NDC 35208-011

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 35208-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Intellipharmaceutics Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1_ven (Fig1 Ven)

A chart showing the fold change and 90% confidence interval in pharmacokinetic parameters for Venlafaxine when interacted with various drugs, including Ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium. The graph includes recommendations related to dosing adjustments or cautions for each interacting drug.*

FDA Label Image

Fig2_ven (Fig2 Ven)

A chart showing the fold change and 90% confidence interval of various interacting drugs analyzed by AnalytePK relative to a reference value. The chart lists drugs such as Ethanol, Diazepam, Alprazolam, Indinavir, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, and Lithium, alongside recommendations regarding dose adjustments or usage restrictions.*

FDA Label Image

Fig3_ven (Fig3 Ven)

A chart depicting pharmacokinetic (PK) changes in venlafaxine with various special populations, including hepatic and renal impairments, CYP2D6 metabolizer status, age, and gender. The graph shows fold changes with 90% confidence intervals relative to reference values, along with dosing recommendations based on these changes.*

FDA Label Image

Ipc_logo (Ipc Logo)

FDA Label Image

Ven_structure (Ven Structure)

Chemical structure of venlafaxine hydrochloride, showing its molecular arrangement including a methoxy-substituted aromatic ring, a cyclohexane ring, and a dimethylaminoethyl side chain with the hydrochloride salt indicated.*

FDA Label Image

Ven150mgoct2018 (Venlafaxine Container Label 150mg 4)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP, containing 150 mg per capsule. The label includes dosage form, strength, and manufacturer IntelliPharmaCeutics Corp. It states the package contains 15 capsules and is Rx only. Storage instructions and a barcode are also visible.*

FDA Label Image

Ven37mgoct2018 (Venlafaxine Container Label 37 5mg 4)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5 mg by IntelliPharmaCeutics Corp. The label indicates a quantity of 15 capsules per container. It includes dosage strength, storage instructions (20° to 25°C), and dispensing notes directing pharmacists to provide a medication guide to patients. Manufacturer address in Toronto, Canada is shown along with NDC 35208-011-15.*

FDA Label Image

Ven75mgoct2018 (Venlafaxine Container Label 75mg 4)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP, 75 mg strength, containing 15 capsules. Manufactured by IntelliPharmaCeutics Corp., Toronto, Canada. The label includes storage instructions, dosage notes, a barcode, and a logo for IntelliPharmaCeutics.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.